查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1732185

全球羊膜穿刺針市場規模：依類型、程序、最終用戶、地區、範圍和預測

Global Amniocentesis Needle Market Size By Type, By Procedure, By End-User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

羊膜穿刺針市場規模及預測

2024年羊膜穿刺針市場規模為 1.8143億美元，預計到2032年將達到 2.2015億美元，2026年至2032年的年複合成長率為 2.7%。

推動全球羊膜穿刺針市場的因素

羊膜穿刺針市場的市場促進因素可能受到多種因素的影響。這些包括：

隨著產婦年齡的成長，羊膜穿刺等產前診斷程序變得越來越受歡迎，因為女性出於各種原因不願生育。這些程序可以評估胎兒的健康狀況、基因異常和其他疾病。

遺傳性疾病的流行羊膜穿刺術等產前診斷技術對於早期發現和治療唐氏症和脊柱裂等遺傳性疾病和染色體異常是必要的。

技術發展：羊膜穿刺針技術已經改進，針頭變得更小、更精確，成像方式更好，出現問題的風險也更低。這些發展使得測試更加安全、更準確，加速了市場發展。

提高意識：產前篩檢和診斷在預防和治療胎兒異常和出生缺陷方面的作用越來越受到準父母和醫療專業人士的認可，支持了市場的成長。

政府措施和醫療保健政策：透過降低產前檢測成本並提高其可近性，特別是對於高風險妊娠，政府舉措、醫療保健政策和償付計劃可以顯著促進市場擴張。

醫療保健支出不斷增加：醫療保健支出不斷增加，尤其是在新興國家，使得更多人能夠獲得先進的產前護理和羊膜穿刺術等診斷程序。

文明病的流行：對羊膜穿刺術等產前診斷技術的需求是由於與影響未出生嬰兒健康的生活方式和環境因素相關的疾病的流行率不斷上升，例如孕婦肥胖、糖尿病和接觸污染物。

懷孕率上升：由於人口成長、生育治療的改善和社會標準的變化等因素導致整體懷孕率上升，羊膜穿刺針市場成長。

積極的法規環境：監管核准和指南透過增強客戶信心和促進產品採用來確保羊膜穿刺術和相關技術的安全性和有效性，推動市場成長。

限制全球羊膜穿刺針市場的因素

有幾個因素可能會對羊膜穿刺針市場造成限制或挑戰。這些包括：

監管障礙：管理醫療設備和程序的嚴格法規可能給生產商和醫療保健從業者帶來挑戰，導致核准延遲和合規成本高昂。

併發症風險：儘管羊膜穿刺術是一項常規手術，但流產是其相關風險之一。如果對相關風險的擔憂導致孕婦不願意接受治療，那麼市場潛力可能會受到限制。

替代篩檢技術：非侵入性產前檢測（NIPT）和其他篩檢技術的發展作為傳統羊膜穿刺術的替代方案，可能會減少對羊膜穿刺針的需求。

倫理與社會考量：產前檢測的倫理問題以及檢測出特定基因異常可能造成的後果可能會影響患者和醫療保健專業人員的決定。這可能會影響羊膜穿刺術的需求。

成本限制：羊膜穿刺術治療費用昂貴，特別是對於保險不足的人來說。成本可能會限制這些手術的可近性，特別是在醫療保健系統不發達或社會經濟地位較低的地區。

技術挑戰：羊膜穿刺術是一種成熟的手術，但需要不斷改進針頭設計和成像技術，以提高安全性和準確性。然而，高昂的研發成本和技術限制可能會阻礙這種進步。

患者的焦慮和恐懼：人們可能會因為害怕手術的疼痛和不適或擔心手術可能產生的結果而猶豫是否接受羊膜穿刺術，這可能會影響市場需求。

知識和教育程度低：羊膜穿刺術未充分利用的原因是患者和醫療保健專業人員對該手術的益處、風險和適應症缺乏了解。

目錄

第1章 全球羊膜穿刺針市場介紹

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章 執行摘要

第3章 已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章 全球羊膜穿刺針市場展望

  • 概述
  • 市場動態
    • 促進因素
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章 全球羊膜穿刺針市場（依類型）

  • 概述
  • 100mm至150mm針頭
  • 大於150mm的針頭
  • 小於100mm的針頭

第6章 全球羊膜穿刺針市場（依程序）

  • 概述
  • 羊膜穿刺術
  • 羊膜腔灌注法
  • 羊水減少法
  • 臍帶穿刺術
  • 胎兒輸血程序

第7章 全球羊膜穿刺針市場（依最終用戶）

  • 概述
  • 醫院
  • 診斷中心
  • 診所
  • 其他

第8章 全球羊膜穿刺針市場（依地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第9章 全球羊膜穿刺針市場的競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第10章 公司簡介

  • Becton, Dickinson and Company
  • Cook Medical
  • RI.MOS. Srl
  • Smiths Medical
  • Laboratoire Ccd
  • Biopsybell
  • Integra Lifesciences
  • Medtronic Plc
  • Coopersurgical
  • Medline

第11章 附錄

  • 相關調查
簡介目錄
Product Code: 32507

Amniocentesis Needle Market Size And Forecast

Amniocentesis Needle Market size was valued at USD 181.43 Million in 2024 and is projected to reach USD 220.15 Million by 2032, growing at a CAGR of 2.7% from 2026 to 2032.

Global Amniocentesis Needle Market Drivers

The market drivers for the Amniocentesis Needle Market can be influenced by various factors. These may include:

Growing Maternal Age: Prenatal diagnostic treatments like amniocentesis, which evaluate foetal health, genetic abnormalities, and other disorders, are becoming more and more popular as women put off having children for a variety of reasons.

Prevalence of Genetic Disorders: Prenatal diagnostic techniques like amniocentesis are necessary for the early detection and treatment of genetic disorders and chromosomal abnormalities, such as Down syndrome, spina bifida, and others, due to their increasing incidence.

Technological Developments: Amniocentesis needle technology has advanced to produce thinner, more accurate needles, better imaging methods, and a lower risk of problems. These developments make the process safer and more accurate, which in turn accelerates market growth.

Expanding Awareness: Prenatal screening and diagnosis's role in preventing or treating foetal anomalies and birth defects is being increasingly recognised by pregnant parents and medical professionals, which supports the market's growth.

Government Initiatives and Healthcare Policies: By lowering the cost and increasing the accessibility of prenatal testing methods, particularly for high-risk pregnancies, government initiatives, healthcare policies, and reimbursement programmes can substantially propel market expansion.

Growing Healthcare Expenditure: More people can now obtain sophisticated prenatal care and diagnostic procedures, such as amniocentesis, thanks to rising healthcare spending, especially in emerging nations.

Prevalence of Lifestyle disorders: The need for prenatal diagnostic techniques like amniocentesis is fueled by the rising prevalence of disorders linked to a lifestyle and environmental factors that impact foetal health, such as mother obesity, diabetes, and exposure to pollutants.

Increase in Pregnancy Rates: The market for amniocentesis needles is growing as a result of the general increase in pregnancy rates, which is being driven by factors like population growth, improvements in fertility treatments, and shifting societal standards.

Positive Regulatory Environment: By boosting customer trust and easing product uptake, regulatory approvals and guidelines guaranteeing the safety and effectiveness of amniocentesis procedures and related technologies promote market growth.

Global Amniocentesis Needle Market Restraints

Several factors can act as restraints or challenges for the Amniocentesis Needle Market. These may include:

Regulatory Obstacles: Tight rules governing medical devices and practices can cause difficulties for producers and healthcare practitioners, resulting in approval delays or higher compliance costs.

Risk of Complications: Miscarriage is one of the hazards associated with amniocentesis, despite it being a regular treatment. The market potential may be limited if expecting mothers are discouraged from undergoing the treatment due to concerns about the associated hazards.

Alternative Screening Technologies: The necessity for amniocentesis needles may be decreased by the development of non-invasive prenatal testing (NIPT) and other screening technologies as alternatives to conventional amniocentesis.

Ethical and Social Considerations: Patients' and healthcare professionals' decisions may be influenced by ethical concerns about prenatal testing and the possible ramifications of detecting specific genetic abnormalities. This could have an effect on the demand for amniocentesis operations.

Cost Restrictions: Amniocentesis treatments can be costly, particularly for those without sufficient insurance. Access to these operations may be restricted due to cost, especially in areas with less developed healthcare systems or lower socioeconomic status.

Technological Challenges: Amniocentesis is a well-established procedure, but to increase safety and accuracy, continuous improvements in needle design and imaging technology would be needed. High research and development expenses or technological constraints, however, may prevent the creation of such advances.

Patient Anxiety and Fear: Some people may be discouraged from having amniocentesis due to fear of the procedure's pain or discomfort or worry about the procedure's possible outcomes, which could impact market demand.

Low Knowledge and Education: Underutilization of amniocentesis may be caused by low knowledge among patients and healthcare professionals on the advantages, dangers, and indications of the treatment, especially in areas with limited access to prenatal care or educational resources.

Global Amniocentesis Needle Market: Segmentation Analysis

The Global Amniocentesis Needle Market is Segmented on the basis of Type, Procedure, End-User, and Geography.

Amniocentesis Needle Market, By Type

100-150 mm Needles

  • Larger Than 150 mm Needles
  • Smaller Than 100 mm Needles

Based on Type, the market is bifurcated into 100-150 mm Needles, Larger than 150 mm Needles, and Smaller Than 100 mm Needles. The 100-150 mm needles segment is expected to hold the largest market share. The factors can be attributed to the suitability of use for most patients and the widespread use of these needles on account of their optimal length.

Amniocentesis Needle Market, By Procedure

  • Amniocentesis Procedures
  • Amnioinfusion Procedures
  • Amnioreduction Procedures
  • Cordocentesis Procedures
  • Fetal Blood Transfusion Procedures

Based on the Procedure, the market is bifurcated into Amniocentesis Procedures, Amnioinfusion Procedures, Amnioreduction Procedures, Cordocentesis Procedures, and Fetal Blood Transfusion Procedures. Amniocentesis Procedures are predicted to hold the most significant CAGR in the forecasted period due to the extensive use of this procedure to diagnose the abnormalities in the developing fetus and the high reliability of the amniocentesis technique.

Amniocentesis Needle Market, By End-User

  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Others

Based on End-User, the market is bifurcated into Hospitals, Diagnostic Centers, Clinics, and Others. Hospitals are anticipated to hold the largest market share. The factors can be credited to the rising number of hospitals and better accessibility & availability of test results in hospitals.

Amniocentesis Needle Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on regional analysis, the Global Amniocentesis Needle Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America owing to the growing healthcare expenditure and increasing government initiatives in this region.

Key Players

  • The major players in the Amniocentesis Needle Market are:
  • Becton Dickinson and Company
  • Cook Medical
  • MOS. Srl
  • Smiths Medical
  • Laboratoire Ccd
  • Biopsybell
  • Integra Lifesciences
  • Rocket Medical plc
  • Teleflex Incorporated
  • Terumo Corporation

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL AMNIOCENTESIS NEEDLE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL AMNIOCENTESIS NEEDLE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2100-150 mm Needles
  • 5.3 Larger Than150 mm Needles
  • 5.4 Smaller Than100 mm Needles

6 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY PROCEDURE

  • 6.1 Overview
  • 6.2 Amniocentesis Procedures
  • 6.3 Amnioinfusion Procedures
  • 6.4 Amnioreduction Procedures
  • 6.5 Cordocentesis Procedures
  • 6.6 Fetal Blood Transfusion Procedures

7 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Diagnostic Centers
  • 7.4 Clinics
  • 7.5 Others

8 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL AMNIOCENTESIS NEEDLE MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Becton, Dickinson and Company
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Cook Medical
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 RI.MOS. Srl
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Smiths Medical
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Laboratoire Ccd
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Biopsybell
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Integra Lifesciences
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Medtronic Plc
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Coopersurgical
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Medline
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 Appendix

  • 11.1 Related Research